Clinical trial
NCCIH Development of Pregnenolone as a Treatment for Depression R61 Phase
NCT03645096 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NCCIH Development of Pregnenolone as a Treatment for Depression R61 Phase
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 1, 2019
- Completion date
- May 31, 2022
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.